Osteoclastogenesis on hydroxyapatite ceramics: The effect of carbonate substitution

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 4, 2010, Pages 1292-1300

  Spence, Gavin ^a   Patel, Nelesh ^a   Brooks, Roger ^a   Bonfield, William ^a   Rushton, Neil ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Carbonate; Hydroxyapatite; Osteoclasts

Indexed keywords

CALCIUM RELEASE; CARBONATE CONTENT; CARBONATE-SUBSTITUTED HYDROXYAPATITE; CELL SIGNALING; CULTURE MEDIUM; HA CERAMICS; HYDROXYAPATITE CERAMICS; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; SURFACE PROFILOMETRY;

APATITE; BIOLOGICAL MATERIALS; CALCIUM; CELL CULTURE; CERAMIC MATERIALS; HYDROXYAPATITE; HYDROXYLATION; SCANNING ELECTRON MICROSCOPY;

CARBONATION;

CARBONIC ACID; CD14 ANTIGEN; HYDROXYAPATITE;

ARTICLE; CALCIUM TRANSPORT; CELL ACTIVITY; CELL SUBPOPULATION; CERAMIC PROSTHESIS; CULTURE MEDIUM; DENTIN; HUMAN; HUMAN CELL; OSTEOCLAST; PHENOTYPE; SCANNING ELECTRON MICROSCOPY;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BONE RESORPTION; BONE SUBSTITUTES; CARBONATES; CELLS, CULTURED; CERAMICS; DURAPATITE; HUMANS; LEUKOCYTES, MONONUCLEAR; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; OSTEOCLASTS; SURFACE PROPERTIES;

EID: 77349103034     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32373     Document Type: Article

References (22)

1. Bigi A, Cojazzi G, Panzavolta S, Ripamonti A, Roveri N, Romanello M, Suarez KN, Moro L. Chemical and structural characterisation of the mineral phase from cortical and trabecular bone. J Inorg Biochem 1997;68:45-51.
2. Driessens FCM. The mineral in bone, dentin and tooth enamel. Bull Soc Chim Belg 1980;89:663.
3. Patel N. In vivo Assessment of Hydroxyapatite and Substituted Apaties for Bone Grafting, PhD Thesis, Cambridge: University of Cambridge; 2003.
4. Hasegawa M, Doi Y, Uchida A. Cell-mediated bioresorption of sintered carbonate apatite in rabbits. J Bone Joint Surg [Br] 2003;85B:142-147.
5. Landi E, Celotti G, Logroscino G, Tampieri A. Carbonated hydroxyapatite as bone substitute. J Eur Ceram Soc 2003;23: 2931-2937.
6. Doi Y, Shibutani T, Moriwaki Y, Kajimoto T, Iwayama Y. Sintered carbonate apatites as bioresorbable bone substitutes. J Biomed Mater Res 1998;39:603-610.
7. Doi Y, Iwanaga H, Shibutani T, Moriwaki Y, Iwayama Y. Osteoclastic responses to various calcium phosphates in cell cultures. J Biomed Mater Res 1999;47:424-433.
8. Redey SA, Razzouk S, Rey C, Bernache-Assollant D, Leroy G, Nardin M, Cournot G. Osteoclast adhesion and activity on synthetic hydroxyapatite, carbonated hydroxyapatite, and naturakl calcium carbonate: Relationship to surface energies. J Biomed Mater Res 1999;45:140-147.
9. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
10. Teitelbaum SL. Bone resorption by osteoclasts. Science 2007;289:1504-1508.
11. Fujikawa Y, Quinn JMW, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996;137:4058-4060.
12. Fuller K, Wong B, Fox S, Choi YW, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998;188:997-1001.
13. Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM, Amling M. Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 2004;25:3963-3972.
14. Akao M, Aoki H, Kato K. Mechanical properties of sintered hydroxyapatite for prosthetic applications. J Mater Sci 1981; 28:809.
15. Gibson IR, Bonfield W. Novel synthesis and characterisation of an AB-type carbonate substituted hydroxyapatite. J Biomed Mater Res 2001;59:697-708.
16. Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-290.
17. LeGeros RZ. Properties of osteoconductive biomaterials: Calcium phosphates. Clin Orthop Rel Res 2002;395:81-98.
18. Ellies LG, Carter JM, Natiella JR, Featherstone JDB, Nelson DGA. Quantitative analysis of early in vivo tissue response to synthetic apatite implants. J Biomed Mater Res 1988;22: 137-148.
19. Patel N, Gibson IR, Hing KA, Best SM, Damien E, Revell PA, Bonfield W. The in vivo response of phase pure hydroxyapatite and carbonate substituted hydroxyapatite granules of varying size ranges. Key Eng Mat Vols 2002; 218-220:383-386.
20. Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S, Udagawa N, Takahashi N. Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 2005;146:5204-5214.
21. Ramaswamy Y, Haynes DR, Berger G, Gildenhaar R, Lucas H, Holding C, Zreiqat H. Bioceramics composition modulate resorption of human osteoclasts. J Mater Sci Mater Med 2005; 16:1199-1205.
22. Botelho CM, Brooks RA, Spence G, McFarlane I, Lopes MA, Best SM, Santos JD, Rushton N, Bonfield W. Differentiation of mononuclear precursors into osteoclasts on the surface of silicon substituted hydroxyapatite. J Biomed Mater Res 2006; 78:708-720.